PATHOPHYSIOLOGY OF IMPORTANT DISEASES Flashcards

(730 cards)

1
Q

(38,425) Mutation at splice site or promoter sequences Ž retained intron in mRNA

A

β-thalassemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

(35) Absent HGPRT leading to increase de novo purine synthesis leading to increase uric acid production

A

Lesch-Nyhan syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

(37,395)Failure of mismatch repair during the S phase Ž microsatellite instability

A

Lynch syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

(45) N-acetylglucosaminyl-1-phosphotransferase defect leading to Golgi mediated
mannose residues phosphorylation failure (leading to decrease mannose-6-phosphate)
leading to increase cellular debris in lysosomes

A

I-cell disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

(49) Type 1 collagen defect due to inability to form triple helices

A

Osteogenesis imperfecta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

(49) Defective ATP7A protein leading to impaired copper absorption and transport
leading to decrease lysyl oxidase activity leading to derease collagen cross-linking

A

Menkes disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

(50) FBN1 mutation on chromosome 15 leading to defective fibrillin (normally forms
sheath around elastin)

A

Marfan syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

(56) Uniparental disomy or imprinting leading to silencing of maternal gene.
Disease expressed when paternal allele deleted or mutated

A

Prader-Willi syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

(56) Silenced gene leading to mutation, lack of expression, or deletion of UBE3A
on maternal chromosome 15

A

Angelman syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

(58) Autosomal recessive
ΔF508 deletion in CFTR gene on chromosome 7
leading to impaired ATP-gated Cl− channel (secretes Cl− in lungs and GI tract,
then reabsorbs Cl− in sweat glands)

A

Cystic fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

(59) Dystrophin gene frameshift mutations leading to loss of anchoring protein to ECM
(dystrophin) leading to myonecrosis

A

Duchenne muscular dystrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

(59) CTG trinucleotide repeat expansion in DMPK gene leading to abnormal expression
of myotonin protein kinase leading to myotonia

A

Myotonic dystrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

(60) Trinucleotide repeat in FMR1 gene leading to hypermethylation leading to decrease expression

A

Fragile X syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

(64) decrease differentiation of epithelial cells into specialized tissue leading to squamous
metaplasia

A

Bitot spots in vitamin A deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

(64) Thiamine deficiency leading to impaired glucose breakdown leading to ATP depletion
worsened by glucose infusion

A

Wernicke encephalopathy in alcoholic
patient given glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

(65) Tryptophan is diverted towards serotonin synthesis leading to B3
deficiency (B3
is
derived from tryptophan)

A

Pellagra in malignant carcinoid
syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

(69) Protein malnutrition leading to decrease oncotic pressure (leading to edema), decrease apolipoprotein
synthesis (leading to liver fatty change)

A

Kwashiorkor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

(70) increase NADH/NAD+ ratio due to ethanol metabolism

A

Lactic acidosis, fasting hypoglycemia,
hepatic steatosis in alcoholism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

(76)  permeability of mitochondrial membrane leading to decrease proton [H+] gradient and
increase O2
consumption leading to uncoupling

A

Aspirin-induced hyperthermia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

(78) Aldolase B deficiency leading to Fructose-1-phosphate accumulates leading to decrease available
phosphate leading to inhibition of glycogenolysis and gluconeogenesis

A

Hereditary fructose intolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

(78) Galactose-1-phosphate uridyltransferase deficiency leading to accumulation of toxic
substances (eg, galactitol in eyes)

A

Classic galactosemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

(79) Lens, retina, Schwann cells lack sorbitol dehydrogenase leading to intracellular
sorbitol accumulation leading to osmotic damage

A

Cataracts, retinopathy, peripheral
neuropathy in DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

(10 Terminal complement deficiencies (C5–C9) Ž failure of MAC formation5)

A

Recurrent Neisseria bacteremia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

(105) C1 esterase inhibitor deficiency leading to unregulated activation of kallikrein
leading to decrease bradykinin

A

Hereditary angioedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
(105) PIGA gene mutation leading to decrease GPI anchors for complement inhibitors (DAF/ CD55, MIRL/CD59) leading to complement-mediated intravascular hemolysis
Paroxysmal nocturnal hemoglobinuria
26
(110) Immediate (minutes): antigen cross links IgE on mast cells leading to degranulation leading to release of histamine and tryptase Late (hours): mast cells secrete chemokines (attract eosinophils) and leukotrienes leading to inflammation, tissue damage
Type I hypersensitivity
27
(110) Antibodies bind to cell-surface antigens leading to cellular destruction, inflammation, cellular dysfunction
Type II hypersensitivity
28
(111) Antigen-antibody complexes leading to activate complement leading to attracts neutrophils
Type III hypersensitivity
29
(111) T cell-mediated (no antibodies involved). CD8+ directly kills target cells, CD4+ releases cytokines
Type IV hypersensitivity
30
(112) Type II hypersensitivity reaction against donor RBCs (usually ABO antigens)
Acute hemolytic transfusion reaction
31
(114) Defect in BTK gene (tyrosine kinase) leading to no B-cell maturation leading to absent B cells in peripheral blood, decrease Ig of all classes
X-linked (Bruton) agammaglobulinemia
32
(114) 22q11 microdeletion leading to failure to develop 3rd and 4th branchial (pharyngeal) pouches
DiGeorge syndrome
33
(115) Defective CD40L on Th cells leading to class switching defect
Hyper-IgM syndrome
34
(115) LFA-1 integrin (CD18) defect leading impaired phagocyte migration and chemotaxis
Leukocyte adhesion deficiency (type 1)
35
(115) LYST mutation leading to microtubule dysfunction leading to phagosome-lysosome fusion defect
Chédiak-Higashi syndrome
36
(115) NADPH oxidase defect leading to decrease ROS, decrease respiratory burst in neutrophils
Chronic granulomatous disease
37
(116) decrease granulocytes (systemic), decrease T cells (local)
Candida infection in immunodeficiency
38
(117) Type IV HSR; HLA mismatch leading to donor T cells attack host cells
Graft-versus-host disease
39
(126) Catalase ⊕ organisms degrade H2 O2 before it can be converted to microbicidal products by the myeloperoxidase system
Recurrent S aureus, Serratia, B cepacia infections in CGD
40
(130) Shiga/Shiga-like toxins inactivate 60S ribosome leading to increase cytokine release
Hemolytic uremic syndrome
41
(130) Tetanospasmin prevents release of inhibitory neurotransmitters (GABA and glycine) from Renshaw cells
Tetanus
42
(130)Toxin (protease) cleaves SNARE leading to decreasie neurotransmitter (ACh) release at NMJ
Botulism
43
(131) Alpha toxin (phospholipase/lecithinase) degrades phospholipids leading to myonecrosis
Gas gangrene
44
(131) TSST-1 and erythrogenic exotoxin A (scarlet) cross-link β region of TCR to MHC class II on APCs outside of antigen binding site leading to increase increase IL-1, IL-2, IFN-γ, TNF-α
Toxic shock syndrome, scarlet fever
45
(131) Lipid A of LPS leading to macrophage activation (TLR4/CD14), complement activation, tissue factor activation
Shock and DIC by gram ⊝ bacteria
46
(126,133) Biofilm production
Prosthetic device infection by S epidermidis
47
(126,134) Dextrans (biofilm) production that bind to fibrin-platelet aggregates on damaged heart valves
Endocarditis 2° to S sanguinis
48
(136) Toxins A and B damage enterocytes leading to watery diarrhea
Pseudomembranous colitis 2° to C difficile
49
(137) Exotoxin inhibits protein synthesis via ADP-ribosylation of EF-2
Diphtheria
50
(138) Cord factor activates macrophages (promoting granuloma formation), induces release of TNF-α; sulfatides (surface glycolipids) inhibit phagolysosomal fusion
Virulence of M tuberculosis
51
(139) Th1 immune response leading to mild
Tuberculoid leprosy
52
(140) Antigenic variation of pilus proteins
No effective vaccine for N gonorrhoeae
53
(143) Fimbriae (P pili)
Cystitis and pyelonephritis by E coli
54
(143) K capsule
Pneumonia, neonatal meningitis by E coli
55
(146) Lack of classic peptidoglycan (reduced muramic acid)
Chlamydiae resistance to β-lactam antibiotics
56
(166) RNA segment reassortment leading to antigenic shift
Influenza pandemics
57
(166) Mutations in hemagglutinin, neuraminidase Ž antigenic drift
Influenza epidemics
58
(169) Binds to ACh receptors leading to retrograde transport (dynein)
CNS invasion by rabies
59
(173) Virus binds CD4 along with CCR5 on macrophages (early), or CXCR4 on T cells (late)
HIV infection
60
(213) Macrophages present antigens to CD4+ and secrete IL-12 Ž CD4+ differentiation into Th1 which secrete IFN-γ leading to macrophage activation
Granuloma
61
(217) Reactivation of telomerase leading to maintains and lengthens telomeres leading to prevention of chromosome shortening and aging
Limitless replicative potential of cancer cells
62
(217) Decrease E-cadherin function leading to decrease intercellular junctions leading to basement membrane and ECM degradation by metalloproteinases leading to cell attachment to ECM proteins (laminin, fibronectin) leading to locomotion leading to vascular dissemination
Tissue invasion by cancer
63
(302) Failure of aorticopulmonary septum formation
Persistent truncus arteriosus
64
(302) Failure of the aorticopulmonary septum to spiral
D-transposition of great arteries
65
(302) Crying, fever, exercise leading to increase RV outflow obstruction leading to increase right-to-left flow across VSD; Squatting leading to increase SVR leading to decrease right-to-left shunt Ž  cyanosis
Tet spells in tetralogy of Fallot
66
(303) Uncorrected left-to-right shunt leading to increase pulmonary blood flow leading to remodeling of vasculature leading to pulmonary hypertension leading to RVH leading to right to left shunting
Eisenmenger syndrome
67
(305) Endothelial cell dysfunction leading to macrophage and LDL accumulation leading to foam cell formation leading to fatty streaks leading to smooth muscle cell migration, extracellular matrix deposition leading to fibrous plaque leading to complex atheromas
Atherosclerosis
68
(306) Cystic medial degeneration
Thoracic aortic aneurysm
69
(308) Rupture of coronary artery atherosclerotic plaque leading to acute thrombosis
Myocardial infarction
70
(308) Subendocardial infarcts (subendocardium vulnerable to ischemia)
Non–ST-segment elevation MI
71
(308) Transmural infarcts
ST-segment elevation MI
72
(309,314) Ventricular arrhythmia
Death within 0-24 hours post MI
73
(309,314) Macrophage-mediated ruptures: papillary muscle (2-7 days), interventricular septum (3-5 days), free wall (5-14 days)
Death or shock within 3-14 days post MI
74
(311) Abnormal accessory pathway from atria to ventricle bypasses the AV node leading to ventricles begin to partially depolarize earlier leading to delta wave. Reentrant circuit leading to supraventricular tachycardia.
Wolff-Parkinson-White
75
(315) Sarcomeric proteins gene mutations (myosin binding protein C and β-myosin heavy chain) leading to concentric hypertrophy (sarcomeres added in parallel). Death due to arrhythmia
Hypertrophic obstructive cardiomyopathy
76
(315) Asymmetric septal hypertrophy, systolic anterior motion of mitral valve Ž outflow obstruction
Syncope, dyspnea in HOCM
77
(317) decrease preload leading to decrease CO
Hypovolemic shock
78
(317) Decrease CO due to left heart dysfunction
Cardiogenic shock
79
(317) Decrease SVR (afterload)
Distributive shock
80
(319) Antibodies against M protein cross react with self antigens; type II HSR
Rheumatic fever
81
(339) 21-hydroxylase deficiency leading to decrease mineralocorticoids, decrease cortisol, increase sex hormones, increase 17-hydroxyprogesterone
Most common form of congenital adrenal hyperplasia
82
(344) Increase Na+-K+ ATPase leading to increase basal metabolic rate leading to increase calorigenesis
Heat intolerance, weight loss in hyperthyroidism
83
(344) Increase CAGs in interstitial space
Myxedema in hypothyroidism
84
(346) Lymphocytic infiltration, fibroblast secretion of GAGs leading to increase osmotic muscle swelling, inflammation
Graves ophthalmopathy
85
(349) Parathyroid adenoma or hyperplasia leading to increase PTH
1° hyperparathyroidism
86
(349) Decrease Ca2+ and/or increase PO4 3– leading to parathyroid hyperplasia leading to increase PTH, increase ALP
2° hyperparathyroidism
87
(342) Increase ADH leading to water retention leading to decrease aldosterone, increase ANB, increase BNP leading to increase urinary Na+ secretion
Euvolemic hyponatremia in SIADH
88
(350) Nonenzymatic glycation of proteins
Small/large vessel disease in DM
89
(351) decrease Insulin or increase insulin requirement leading to increase fat breakdown leading to increase free fatty acids leading to increase ketogenesis
Diabetic ketoacidosis
90
(351) Hyperglycemia leading to increase serum osmolality, excessive osmotic diuresis
Hyperosmolar hyperglycemic state
91
(357) Gastrin-secreting tumor (gastrinoma) of pancreas or duodenum leading recurrent ulcers in duodenum/jejunum and malabsorption
Zollinger-Ellison syndrome
92
(366) Failure to recanalize
Duodenal atresia
93
(366) Disruption of SMA leading to ischemic necrosis of fetal intestine
Jejunal/ileal atresia
94
(370) Compression of transverse (third) portion of duodenum by SMA and aorta
Superior mesenteric artery syndrome
95
(383) Loss of postganglionic inhibitory neurons (contain NO and VIP) in myenteric plexus leading to failure of LES relaxation
Achalasia
96
(385) Replacement (metaplasia) of nonkeratinized stratified squamous epithelium with intestinal epithelium (nonciliated columnar with goblet cells)
Barrett esophagus
97
(386) Decrease PGE2 leading to decrease gastric protection
Acute gastritis 2° to NSAIDs
98
(388) Autoimmune-mediated intolerance of gliadin (found in wheat) Ž malabsorption (distal duodenum, proximal jejunum), steatorrhea
Celiac disease
99
(389) Transmural inflammation
Fistula formation in Crohn
100
(391) Persistence of the vitelline (omphalomesenteric) duct
Meckel diverticulum
101
(391) Loss of function mutation in RET leading to failure of neural crest migration leading to lack of ganglion cells/enteric nervous plexuses in distal colon
Hirschsprung disease
102
(395) Loss of APC (decrease intercellular adhesion, increase proliferation) leading to KRAS mutation (unregulated intracellular signaling) leading to loss of tumor suppressor genes (TP53, DCC)
Adenoma-carcinoma sequence in colorectal cancer
103
(396) Stellate cells
Fibrosis in cirrhosis
104
(397)
Reye syndrome
105
(398) Cirrhosis leading to portosystemic shunts leading to decrease NH3 metabolism
Hepatic encephalopathy
106
(400) Misfolded proteins aggregate in hepatocellular ER leading to cirrhosis. In lungs, decrease α1 -antitrypsin leading to uninhibited elastase in alveoli leading to panacinar emphysema
α1 -antitrypsin deficiency
107
(402) Mutated hepatocyte copper-transporting ATPase (ATP7B on chromosome 13) leading to decrease copper incorporation into apoceruloplasmin, excretion into bile leading to decrease serum ceruloplasmin, increase copper in tissues and urine
Wilson disease
108
(402) HFE mutation on chromosome 6 decrease hepcidin production, increase intestinal absorption leading to iron overload (increase ferritin,increase iron, decrease TIBC leading to increase transferrin saturation)
Hemochromatosis
109
(403) Fistula between gallbladder and GI tract leading to stone enters GI lumen leading to obstructing ileocecal valve (narrowest point)
Gallstone ileus
110
(403) Biliary tree obstruction leading to stasis/bacterial overgrowth
Acute cholangitis
111
(404) Autodigestion of pancreas by pancreatic enzymes
Acute pancreatitis
112
(411) Rh ⊝ mother form antibodies (maternal anti-D IgG) against RBCs of Rh ⊕ fetus
Rh hemolytic disease of the newborn
113
(425) Lead inhibits ferrochelatase and ALA dehydratase leading to decrease heme synthesis, increase RBC protoporphyrin.
Anemia in lead poisoning
114
(427) Inflammation leading to increase hepcidin leading to decrease release of iron from macrophages, decrease iron absorption from gut
Anemia of chronic disease
115
(428) Defect in G6PD leading to decrease NADPH leading to decrease reduced glutathione leading to increase RBC susceptibility to oxidant stress
G6PD deficiency
116
(428) Point mutation leading to substitution of glutamic acid with valine in β chain leading to low O2 , high altitude, acidosis precipitates sickling (deoxygenated HbS polymerizes) leading to anemia, vaso-occlusive disease
Sickle cell anemia
117
(432) Decrease GpIb leading to decrease platelet-to-vWF adhesion
Bernard-Soulier syndrome
118
(432) Decrease GpIIb/IIIa leading to decrease platelet-to-platelet aggregation, defective platelet plug formation
Glanzmann thrombasthenia
119
( 432) Decrease ADAMTS13 (a vWF metalloprotease) leading to decrease degradation of vWF multimers leading to increase platelet adhesion and aggregation (microthrombi formation)
Thrombotic thrombocytopenic purpura
120
(433) Decrease vWF leading to decrease platelet-to-vWF adhesion, possibly possibly PTT (vWF protects factor VIII)
von Willebrand disease
121
(433) Mutant factor V (Arg506Gln) that is resistant to degradation by protein C
Factor V Leiden
122
(450) Fractured surgical neck or anterior dislocation of humerus leading to flattened deltoid
Axillary nerve injury
123
(450) Compression of axilla (use of crutches), midshaft humerus fracture, repetitive pronation/supination of forearm leading to wrist/finger drop, decreased grip strength
Radial nerve injury (“Saturday night palsy”)
124
(450) Proximal lesion: supracondylar fracture leading to loss of sensation over thenar eminence, dorsal and palmar aspect of lateral 3½ fingers Distal lesion: carpal tunnel syndrome
Median nerve injury (Ape’s hand/ Pope’s blessing)
125
(450) Proximal lesion: fractured medial epicondyle leading to radial deviation of wrist on flexion Distal lesion: fractured hook of hamate leading to ulnar claw on digital extension
Ulnar nerve injury
126
(452) Traction/tear of C5-C6 roots during delivery on the neck of the infant, and due to trauma in adults
Erb palsy (waiter’s tip)
127
(452) Traction/tear of C8-T1 roots during delivery on the arm of the infant, and on trying to grab a branch in adults
Klumpke palsy
128
(452) Injury to long thoracic nerve (C5-C7), like on axillary node dissection during mastectomy
Winged scapula
129
(457) Trauma on lateral aspect of leg or fracture of fibular neck leading to foot drop with steppage gait
Common peroneal nerve injury
130
(457)Iatrogenic injury during IM injection at gluteal region leading to Trendelenburg sign: lesion contralateral to side of hip that drops due to adductor weakness
Superior gluteal nerve injury
131
(457) Injury during horseback riding or prolonged cycling; can be blocked during delivery at the ischial spine
Pudendal nerve injury
132
(466) Nursemaid’s elbow; due to sudden pull on arm (in children)
Radial head subluxation
133
(466) Obese young adolescent with hip/knee pain. Increased axial force on femoral head leading to epiphysis displaces relative to femoral neck like a scoop of ice cream slips off a cone
Slipped capital femoral epiphysis
134
(467) Constitutive activation of FGFR3 leading to decrease chondrocyte proliferation leading to failure of endochondral ossification leading to short limbs67)
Achondroplasia
135
(467) Increase osteoclast activity leading to increase bone resorption secondary to decrease estrogen levels and old age.
Osteoporosis
136
(468) Carbonic anhydrase II mutations leading to decrease ability of osteoclasts to generate acidic environment leading to decrease bone resorption leading to dense bones prone to fracture, pancytopenia (decrease marrow space)
Osteopetrosis
137
(468) Increase osteoclast activity followed by increase osteoblast activity leading to poor quality bone formed that is prone to fractures.
Osteitis deformans
138
(472) Mechanical degeneration of articular cartilage causing inflammation with inadequate repair and osteophyte formation.
Osteoarthritis
139
(472) Autoimmune inflammation due to HLA-DR4 causing pannus formation. Type III Hypersensitivity reaction.
Rheumatoid arthritis
140
(474) Autoimmune Type IV hypersensitivity reaction leading to lymphocyte mediated damage of exocrine glands
Sjogren syndrome
141
(476) Predominantly a Type III hypersensitivity reaction with decrease clearance of immune complexes. Hematologic manifestations are a type II hypersensitivity reaction.
Systemic lupus erythematosus
142
(472) Mechanical degeneration of articular cartilage causing inflammation with inadequate repair and osteophyte formation.
Osteoarthritis
143
(472) Autoimmune inflammation due to HLA-DR4 causing pannus formation. Type III Hypersensitivity reaction
Rheumatoid arthritis
144
(474) Autoimmune Type IV hypersensitivity reaction leading to lymphocyte mediated damage of exocrine glands.
Sjogren syndrome
145
(476) Predominantly a Type III hypersensitivity reaction with decreased clearance of immune complexes. Hematologic manifestations are a type II hypersensitivity reaction.
Systemic lupus erythematosus
146
(478) Ophthalmic artery occlusion
Blindness in giant cell (temporal) arteritis
147
(480) Autoantibodies to postsynaptic nicotinic (ACh) receptors
Myasthenia gravis
148
(480) Autoantibodies to presynaptic calcium channels leading to decrease ACh release
Lambert-Eaton myasthenic syndrome
149
(484) Normal melanocyte number, decrease melanin production
Albinism
150
(484) Autoimmune destruction of melanocytes
Vitiligo
151
(485) Epidermal barrier dysfunction, genetic factors (ie, loss-of-function mutations in the filaggrin [FLG] gene), immune dysregulation, altered skin microbiome, environmental triggers of inflammation
Atopic dermatitis
152
(485) Type IV HSR. During the sensitization phase, Allergen activates Th1 cells leading to memory CD4+ cells and CD8+ form. Upon reexposure leading to CD4+ cells release cytokines and Cd8+ cells kill targeted cells
Allergic contact dermatitis
153
(485) Disrupted skin barrier leading to activation of dendritic cells via inflammatory cytokines (IL-1B, IL-6, TNF) leading to activated dendritic cells release IL-23 leading to Naive T cells form Th1 (IL-12) and Th17 (IL-23) cells that secrete IFN-y and IL-17A/IL-22 respectively leading to Acanthosis, parakeratosis, hypogranulosis
Psoriasis
154
(489) Type II HSR. IgG autoantibodies form against desmoglein 1 and 3 in desmosomes leading to separation of keratinocytes in stratum spinosum from stratum basale
Pemphigus vulgaris
155
(489) Type II HSR. IgG autoantibodies against hemidesmosomes leading to separation of epidermis from dermis
Bullous pemphigoid
156
(501)Failure of caudal neuropore to fuse by 4th week of development
Spina bifida occulta, meningocele, myelomeningocele, myeloschisis
157
(501) Failure of rostral neuropore to close leading to no forebrain, open calvarium
Anencephaly
158
(501) Failure of the forebrain (prosencephalon) to divide into 2 cerebral hemispheres; developmental field defect typically occurring at weeks 3-4 of development; associated with SHH mutations
Holoprosencephaly
159
(501) Failure of neuronal migration leading to smooth brain surface lacking sulci and gyri
Lissencephaly
160
(502) Downward displacement of cerebellar tonsils inferior to foramen magnum
Chiari I malformation
161
(502) Herniation of cerebellum (vermis and tonsils) and medulla through foramen magnum leading to noncommunicating hydrocephalus
Chiari II malformation
162
(502) Agenesis of cerebellar vermis leading to cystic enlargement of 4th ventricle that fills the enlarged posterior fossa; associated with noncommunicating hydrocephalus
Dandy-Walker malformation
163
(502) Fluid-filled, gliosis-lined cavity within spinal cord, associated with Chiari I malformation (low-lying cerebellar tonsils), less commonly with infections, tumors, trauma
Syringomyelia
164
(526) Lesion in the dominant parietal cortex leading to agraphia, acalculia, finger agnosia, left-right disorientation
Gerstmann syndrome
165
(526) Lesion in the nondominant parietal cortex
Hemispatial neglect syndrome
166
(526) Bilateral lesions in the amygdala; seen in HSV-1 encephalitis leading to disinhibition, including hyperphagia, hypersexuality, hyperorality
Klüver-Bucy syndrome
167
(526) Lesion in the dorsal midbrain; often due to pineal gland tumors
Parinaud syndrome (inability to move eyes up and down)
168
(527) Fluid accumulation in the brain parenchyma leading to increase ICP; may be cytotoxic (intracellular fluid accumulation due to osmotic shift; associated with early ischemia, hyperammonemia, SIADH) or vasogenic (extracellular fluid accumulation due to increased permeability of BBB; associated with late ischemia, trauma, hemorrhage, inflammation, tumors)
Cerebral edema
169
(528) Stroke in dominant (usually left) hemisphere, in either the superior temporal gyrus of temporal lobe (Wernicke; receptive aphasia) or inferior frontal gyrus of frontal lobe (Broca; expressive aphasia)
Aphasia
170
(528) Stroke of the basilar artery
Locked-in syndrome (loss of horizontal, but not vertical, eye movements)
171
(528) Stroke of the anterior inferior cerebellar artery
Lateral pontine syndrome
172
(529) Stroke of the posterior inferior cerebellar artery
Lateral medullary (Wallenberg) syndrome
173
(529) Stroke of the anterior spinal artery
Medial medullary syndrome
174
(529) Reduced glial fiber support and impaired autoregulation of BP in premature infants leading to bleeding into the ventricles, originating in the germinal matrix (a highly vascularized layer within the subventricular zone)
Neonatal intraventricular hemorrhage
175
(530) Rupture of middle meningeal artery, often secondary to skull fracture involving the pterion
Epidural hematoma
176
(530) Rupture of bridging veins; acute (traumatic, high-energy impact, sudden deceleration injury) or chronic (mild trauma, cerebral atrophy, increase age, chronic alcohol overuse, shaken baby syndrome)
Subdural hematoma
177
(530) Trauma, rupture of aneurysm (such as a saccular aneurysm), or arteriovenous malformation leading to bleeding
Subarachnoid hemorrhage
178
(530) Systemic hypertension (most often occur in the putamen of basal ganglia, thalamus, pons, and cerebellum), amyloid angiopathy, arteriovenous malformation, vasculitis, neoplasm, or secondary to reperfusion injury in ischemic stroke leading to bleeding
Intraparenchymal hemorrhage
179
(531) Most commonly following amputation leading to reorganization of primary somatosensory cortex leading to sensation of pain in a limb that is no longer prese
Phantom limb pain
180
(531) Traumatic shearing of white matter tracts during rapid acceleration and/or deceleration of the brain (eg, motor vehicle accident) leading to multiple punctate hemorrhages involving white matter tracts leading to neurologic injury, often causing coma or persistent vegetative state
Diffuse axonal injury
181
(531) Damage to the arcuate fasciculus
Conduction aphasia
182
(531) Damage to both Broca (inferior frontal gyrus of frontal lobe) and Wernicke (superior temporal gyrus of temporal lobe) areas
Global aphasia
183
(532) Inability of body to dissipate heat (eg, exertion) leading to CNS dysfunction (eg, confusion), rhabdomyolysis, acute kidney injury, ARDS, DIC
Heat stroke
184
(534) Irritation of CN V, meninges, or blood vessels (release of vasoactive neuropeptides [eg, substance P, calcitonin gene-related peptide])
Migraine
185
(536) Loss of dopaminergic neurons of substantia nigra pars compacta
Parkinson disease
186
(536) Trinucleotide (CAG) repeat expansion in huntingtin (HTT) gene on chromosome 4 leading to toxic gain of function leading to atrophy of caudate and putamen with ex vacuo ventriculomegaly leading to increase dopamine, decrease GABA, decrease ACh in brain leading to neuronal death via glutamate excitotoxicity
Huntington disease
187
(536) Widespread cortical atrophy, narrowing of gyri and widening of sulci; senile plaques in gray matter composed of beta-amyloid core (formed by cleavage of amyloid precursor protein); neurofibrillary tangles composed of intracellular, hyperphosphorylated tau protein; Hirano bodies (intracellular eosinophilic proteinaceous rods in hippocampus)
Alzheimer disease
188
(536) Frontotemporal lobe degeneration leading to decrease executive function and behavioral inhibition
Frontotemporal dementia
189
(537) Multiple arterial infarcts and/or chronic ischemia
Vascular dementia
190
(537) Secondary to diffuse gray matter and subcortical atrophy
HIV-associated dementia
191
(538) Increased ICP, associated with dural venous sinus stenosis; impaired optic nerve axoplasmic flow leading to papilledema
Idiopathic intracranial hypertension
192
(538)Reduced CSF absorption by arachnoid granulations (eg, arachnoid scarring post-meningitis leading to increase ICP, papilledema, herniation
Communicating hydrocephalus
193
(538) Idiopathic, CSF pressure elevated only episodically, no increase subarachnoid space volume; expansion of ventricles distorts the fibers of the corona radiata
Normal pressure hydrocephalus
194
(538) Structural blockage of CSF circulation within ventricular system (eg, stenosis of aqueduct of Sylvius, colloid cyst blocking foramen of Monro, tumor)
Noncommunicating hydrocephalus
195
(539) Autoimmune inflammation and demyelination of CNS (brain and spinal cord) leading to axonal damage
Multiple sclerosis
196
(540) Rapid osmotic changes, most commonly iatrogenic correction of hyponatremia but also rapid shifts of other osmolytes (eg, glucose) leading to massive axonal demyelination in pontine white matter
Osmotic demyelination syndrome
197
(540) Autoimmune destruction of Schwann cells via inflammation and demyelination of motor and sensory fibers and peripheral nerves; likely facilitated by molecular mimicry and triggered by inoculations or stress
Acute inflammatory demyelinating polyneuropathy (subtype of GuillainBarré syndrome)
198
(540) Defective production of proteins involved in the structure and function of peripheral nerves or the myelin sheath
Charcot-Marie-Tooth disease
199
(540) Destruction of oligodendrocytes secondary to reactivation of latent JC virus infection leading to demyelination of CNS
Progressive multifocal leukoencephalopathy
200
(541) Somatic mosaicism of an activating mutation in one copy of the GNAQ gene leading to congenital anomaly of neural crest derivatives leading to capillary vascular malformation, ipsilateral leptomeningeal angioma with calcifications, episcleral hemangioma
Sturge-Weber syndrome
201
(542) Hyperplasia of only one type of endocrine cells found in pituitary (most commonly from lactotrophs, producing prolactin)
Pituitary adenoma
202
(546) Congenital degeneration of anterior horns
Spinal muscular atrophy
203
(546) Can be caused by defect in superoxide dismutase 1
Amyotrophic lateral sclerosis
204
(546) Degeneration/demyelination of dorsal columns and roots leading to progressive sensory ataxia (impaired proprioception leading to poor coordination)
Tabes dorsalis
205
(546) Poliovirus infection spreads from lymphoid tissue of oropharynx to small intestine and then to CNS via bloodstream leading to destruction of cells in anterior horn of spinal cord (LMN death)
Poliomyelitis
206
(547) Trinucleotide repeat disorder (GAA) on chromosome 9 in gene that encodes frataxin (iron-binding protein) leading to impairment in mitochondrial functioning leading to degeneration of lateral corticospinal tract, spinocerebellar tract, dorsal columns, and dorsal root ganglia
Friedreich ataxia
207
(550) Damage to stereociliated cells in organ of Corti leading to loss of high-frequency hearing first; sudden extremely loud noises can lead to tympanic membrane rupture leading to hearing loss
Noise-induced hearing loss
208
(550)Destruction of hair cells at the cochlear base (preserved low-frequency hearing at apex) leading to aging-related progressive bilateral/symmetric sensorineural hearing loss (often of higher frequencies)
Presbycusis
209
(550) Abnormal growth of keratinized squamous epithelium in middle ear
Cholesteatoma
210
(550) Increased endolymph in inner ear leading to vertigo, hearing loss, tinnitus and ear fullness
Ménière disease
211
(551) Eye too short for refractive power of cornea and lens leading to light focused behind retina
Hyperopia
212
(551) Eye too long for refractive power of cornea and lens leading to light focused in front of retina
Myopia
213
(551) Abnormal curvature of cornea leading to different refractive power at different axes
Astigmatism
214
(552) Aging-related impaired accommodation, primarily due to decrease lens elasticity
Presbyopia
215
(553) Optic neuropathy causing progressive vision loss (peripheral leading to central), usually accompanied by increased intraocular pressure
Glaucoma
216
(533) Associated with increased resistance to aqueous humor drainage through trabecular meshwork
Open-angle glaucoma
217
(533Anterior chamber angle is narrowed or closed; associated with anatomic abnormalities (eg, anteriorly displaced lens resting against central iris) leading to decrease aqueous flow through pupil leading to increase pressure in posterior chamber leading to peripheral iris pushed against cornea Ž obstruction of drainage pathways by the iris)
Angle-closure glaucoma
218
(554) Chronic hyperglycemia leading to increase permeability and occlusion of retinal vessels leading to microaneurysms, hemorrhages (nonproliferative); retinal neovascularization due to chronic hypoxia (proliferative)
Diabetic retinopathy
219
(554) Chronic hypertension leading to spasm, sclerosis, and fibrinoid necrosis of retinal vessels
Hypertensive retinopathy
220
(554) Blockage of central or branch retinal artery usually due to embolism (carotid artery atherosclerosis > cardiogenic); less commonly due to giant cell arteritis
Retinal artery occlusion
221
(554) Primary thrombosis leading to central retinal vein occlusion; secondary thrombosis at arteriovenous crossings (sclerotic arteriole compresses adjacent venule causing turbulent blood flow) leading to branch retinal vein occlusion
Retinal vein occlusion
222
(554) Separation of neurosensory retina from underlying retinal pigment epithelium leading to loss of choroidal blood supply leading to hypoxia and degeneration of photoreceptors; due to retinal tears (rhegmatogenous) or tractional or exudative (fluid accumulation) (nonrhegmatogenous)
Retinal detachment
223
(554) Progressive degeneration of photoreceptors and retinal pigment epithelium
Retinitis pigmentosa
224
(554) Increase ICP (eg, secondary to mass effect) leading to impaired axoplasmic flow in optic nerve leading to optic disc swelling (usually bilateral)
Papilledema
225
(556) Unilateral or asymmetric lesions of afferent limb of pupillary reflex (eg, retina, optic nerve)
Relative afferent pupillary defect
226
(557) Lesions along the sympathetic chain: 1st neuron (pontine hemorrhage, lateral medullary syndrome, spinal cord lesion above T1 like BrownSequard syndrome or late-stage syringomyelia); 2nd neuron (stellate ganglion compression by Pancoast tumor); 3rd neuron (carotid dissection)
Horner syndrome
227
(559) Secondary to pituitary tumor mass effect, carotid-cavernous fistula, or cavernous sinus thrombosis related to infection (spreads due to lack of valves in dural venous sinuses)
Cavernous sinus syndrome
228
(577) Usually secondary to illnesses (eg, CNS disease, infection, trauma, substance use), or medications (eg, anticholinergics)
Delirium
229
(579) Altered dopaminergic activity, increase serotonergic activity, decrease dendritic activity
Schizophrenia
230
(613) Inability of α-intercalated cells to secrete H+ leading to no new HCO3– generated leading to metabolic acidosis
Distal RTA (type 1)
231
(613) Defective PCT HCO3– reabsorption leading to increase excretion of HCO3– in urine leading to metabolic acidosis
Proximal RTA (type 2)
232
(613) Hypoaldosteronism/aldosterone resistance leading to increase K+ leading to NH3 synthesis in PCT leading to decrease NH 4 + excretion
Hyperkalemic tubular acidosis (type 4)
233
(615) Glomerular inflammation leading to GBM damage leading to loss of RBCs in urine leading to dysmorphic RBCs, hematuria
Nephritic syndrome
234
(615) Podocyte damage leading to impaired charge barrier leading to proteinuria
Nephrotic syndrome
235
(615) Severe GBM damage leading to loss of RBCs in urine + impaired charge barrier leading to hematuria + proteinuria
Nephritic-nephrotic syndrome
236
(616) Type III HSR with consumptive hypocomplementemia
Infection-associated glomerulonephritis
237
(617)Type IV collagen mutation (X-linked dominant) leading to irregular thinning and thickening and splitting of GBM leading to nephritic syndrome
Alport syndrome
238
(620) Outlet incompetence (urethral hypermobility/intrinsic sphincter deficiency) leading to leak on increase intraabdominal pressure
Stress incontinence
239
(620) Detrusor overactivity leading to leak with urge to void
Urge incontinence
240
(620) Incomplete emptying (detrusor underactivity or outlet obstruction) leading to leak with overfilling
Overflow incontinence
241
(622) Decrease RBF leading to decrease GFR leading to increase reabsorption of Na+/H2O and urea
Prerenal azotemia
242
(622) Patchy necrosis leading to debris obstructing tubules and fluid backflow leading to decrease GFR
Intrinsic renal failure
243
(622) Outflow obstruction (bilateral)
Postrenal azotemia
244
(645) Twisting of ovary/fallopian tube around infundibulopelvic ligament and ovarian ligament leading to venous/lymphatic blockage leading to arterial inflow continued leading to edema leading to blockade of arterial inflow leading to necrosis
Adnexal torsion
245
(662) Abnormal placental spiral arteries leading to endothelial dysfunction, vasoconstriction, ischemia leading to new-onset HTN with proteinuria
Preeclampsia
246
(663) Supine position leading to compressed abdominal aorta and IVC by gravid uterus leading to decrease placental perfusion and decrease venous return
Supine hypotensive syndrome
247
(665) Severe caloric restriction, increase energy expenditure, and/or stress leading to altered pulsatile GnRH secretion leading to decrease LH, FSH, estrogen
Functional hypothalamic amenorrhea
248
(665) Hyperinsulinemia and/or insulin resistance leading to altered hypothalamic feedback response leading to increase LH:FSH, increase androgens, decrease rate of follicular maturation leading to unruptured follicles (cysts) + anovulation
Polycystic ovarian syndrome
249
(671) Dilated veins in pampiniform plexus due to increase venous pressure leading to enlarged scrotum
Varicocele
250
(690) Oxidized Hb secondary to dapsone, local anesthetics, nitrites leading to Hb oxidization (Fe2+) leading to decrease O2 binding but leading to cyanide affinity leading to tissue hypoxia
Deep venous thrombosis
251
(697) Noncaseating granulomas leading to increase macrophage activity leading to increase 1α-hydroxylase activity in macrophage leading to vitamin D activation leading to increase Ca2+
Sarcoidosis associated hypercalcemia
252
(699) Alveolar injury leading to inflammation leading to capillary endothelial damage and increase vessel permeability leading to leakage of protein-rich fluid into alveoli leading to intra-alveolar hyaline membranes and noncardiogenic pulmonary edema leading to decrease compliance and V/Q mismatch leading to hypoxic vasoconstriction leading to increase pulmonary vascular resistance
Acute respiratory distress syndrome
253
(699) Respiratory effort against airway obstruction (obstructive); impaired respiratory effort due to CNS injury/toxicity, CHF, opioids (central); obesity leading to hypoventilation leading to increase PaCO2 during waking hours
Sleep apnea
254
(35) Gout, intellectual disability, self-mutilating behavior in a boy
Lesch-Nyhan syndrome (HGPRT deficiency, X-linked recessive)
255
(47) Situs inversus, chronic ear infections, sinusitis, bronchiectasis, infertility
Primary ciliary dyskinesia (Kartagener syndrome)
256
(49) Blue sclera, multiple fractures, dental problems, conductive hearing loss
Osteogenesis imperfecta (type I collagen defect)
257
(49) Elastic skin, hypermobility of joints,  bleeding tendency
Ehlers-Danlos syndrome (type V collagen defect, type III collagen defect seen in vascular subtype of ED)
258
(50) Arachnodactyly, lens dislocation (upward and temporal), aortic dissection, hyperflexible joints
Marfan syndrome (fibrillin defect)
259
(50) Arachnodactyly, pectus deformity, lens dislocation (downward)
Homocystinuria (autosomal recessive)
260
(55) Café-au-lait spots (unilateral), polyostotic fibrous dysplasia, precocious puberty, multiple endocrine abnormalities
McCune-Albright syndrome (Gs-protein activating mutation)
261
(58) Meconium ileus in neonate, recurrent pulmonary infections, nasal polyps, pancreatic insufficiency, infertility/subfertility
Cystic fibrosis (CFTR gene defect, chromosome 7, ∆F508)
262
(59) Calf pseudohypertrophy
Muscular dystrophy (most commonly Duchenne, due to X-linked recessive frameshift mutation of dystrophin gene)
263
(59) Child uses arms to stand up from squat
Duchenne muscular dystrophy (Gowers sign)
264
(59) Slow, progressive muscle weakness in boys
Becker muscular dystrophy (X-linked non-frameshift deletions in dystrophin; less severe than Duchenne
265
(61) Infant with cleft lip/palate, microcephaly or holoprosencephaly, polydactyly, cutis aplasia
Patau syndrome (trisomy 13)
266
(61) Infant with microcephaly, rocker-bottom feet, clenched hands, and structural heart defect
Edwards syndrome (trisomy 18)
267
(61) Single palmar crease, intellectual disability
Down syndrome
268
(62) Microcephaly, high-pitched cry, intellectual disability
Cri-du-chat (cry of the cat) syndrome
269
(64) Confusion, ophthalmoplegia/nystagmus, ataxia
Wernicke encephalopathy (add confabulation/memory loss for Korsakoff syndrome)
270
(64) Dilated cardiomyopathy/high-output heart failure, edema, alcoholism or malnutrition
Wet beriberi (thiamine [vitamin B1] deficiency)
271
(65) Burning feet syndrome
Vitamin B5 deficiency
272
(65) Dermatitis, dementia, diarrhea
Pellagra (niacin [vitamin B3] deficiency)
273
(67) Swollen gums, mucosal bleeding, poor wound healing, petechiae, corkscrew hairs, perifollicular hemorrhages
Scurvy (vitamin C deficiency: can’t hydroxylate proline/ lysine for collagen synthesis); tea and toast diet
274
(68) Bowlegs (children), bone pain, and muscle weakness
Rickets (children), osteomalacia (adults); vitamin D deficiency
275
(69) Hemorrhagic disease of newborn with increase PT, increase aPTT
Vitamin K deficiency
276
(82) Intellectual disability, musty body odor, hypopigmented skin, eczema
Phenylketonuria
277
(82) Bluish-black connective tissue, ear cartilage, sclerae; urine turns black on prolonged exposure to air
Alkaptonuria (homogentisate oxidase deficiency; ochronosis)
278
(85) Infant with hypoglycemia, hepatomegaly, cardiomyopathy
Cori disease (debranching enzyme deficiency) or von Gierke disease (glucose-6-phosphatase deficiency, more severe)
279
(85) Chronic exercise intolerance with myalgia, fatigue, painful cramps, myoglobinuria
McArdle disease (skeletal muscle glycogen phosphorylase deficiency)
280
(86) Cherry-red spots” on macula
Tay-Sachs (ganglioside accumulation; no hepatosplenomegaly); Niemann-Pick disease (sphingomyelin accumulation; hepatosplenomegaly); central retinal artery occlusion
281
(86) Hepatosplenomegaly, pancytopenia, osteoporosis, avascular necrosis of femoral head, bone crises
Gaucher disease (glucocerebrosidase [β-glucosidase] deficiency)
282
(92) Achilles tendon xanthoma
Familial hypercholesterolemia (decrease LDL receptor signaling)
283
(114) Male child, recurrent infections, no mature B cells
Bruton disease (X-linked agammaglobulinemia)
284
(114) Anaphylaxis following blood transfusion
IgA deficiency
285
(114) Recurrent cold (noninflamed) abscesses, eczema, high serum IgE, increase eosinophils
Hyper-IgE syndrome (Job syndrome: neutrophil chemotaxis abnormality)
286
(115) Late separation (>30 days) of umbilical cord, no pus, recurrent skin and mucosal bacterial infections
Leukocyte adhesion deficiency (type 1; defective LFA-1 integrin)
287
(115) Recurrent infections and granulomas with catalase ⊕ organisms
Chronic granulomatous disease (defect of NADPH oxidase)
288
(133) Fever, vomiting, diarrhea, desquamating rash following use of nasal pack or tampon
Staphylococcal toxic shock syndrome
289
(134) “Strawberry tongue
Scarlet fever (sandpaper rash); Kawasaki disease (lymphadenopathy, high fever for 5 days
290
(135) Colon cancer associated with infective endocarditis
Streptococcus bovis
291
(136) Flaccid paralysis in newborn after ingestion of honey
Clostridium botulinum infection (floppy baby syndrome)
292
(136) Abdominal pain, diarrhea, leukocytosis, recent antibiotic use
Clostridioides difficile infection
293
(137) Tonsillar pseudomembrane with “bull’s neck” appearance
Corynebacterium diphtheria infection
294
(138) Back pain, fever, night sweats
Pott disease (vertebral TB)
295
(140) Adrenal insufficiency, fever, bilateral adrenal hemorrhage
Waterhouse-Friderichsen syndrome (meningococcemia)
296
(143) Red “currant jelly” sputum in patients with alcohol overuse or diabetes
Klebsiella pneumoniae pneumonia
297
(144) Fever, chills, headache, myalgia following antibiotic treatment for syphilis
Jarisch-Herxheimer reaction (due to host response to sudden release of bacterial antigens
298
(144) Large rash with bull’s-eye appearance
Erythema migrans from Ixodes tick bite (Lyme disease: Borrelia)
299
(145) Ulcerated genital lesion
Nonpainful, indurated: chancre (1° syphilis, Treponema pallidum) Painful, with exudate: chancroid (Haemophilus ducreyi)
300
(145) Smooth, moist, painless, wartlike white lesions on genitals
Condylomata lata (2° syphilis)
301
(145) Pupil accommodates but doesn’t react to light
Neurosyphilis (Argyll Robertson pupil)
302
(147) Dog or cat bite resulting in infection (cellulitis, osteomyelitis)
Pasteurella multocida (cellulitis at inoculation site)
303
(148) Atypical "walking pneumonia" with x-ray looking worse than the patient
Mycoplasma pneumoniae infection
304
(148) Rash on palms and soles
Coxsackie A, 2° syphilis, Rocky Mountain spotted fever
305
(150) Black eschar on face of patient with diabetic ketoacidosis and/or neutropenia
Mucor or Rhizopus fungal infection
306
(153) Chorioretinitis, hydrocephalus, intracranial calcifications
Congenital toxoplasmosis
307
(161)Child with fever later develops red rash on face that spreads to body
Erythema infectiosum/fifth disease (“slapped cheeks” appearance, caused by parvovirus B19
308
(156) Pruritus, serpiginous rash after walking barefoot
Hookworm (Ancylostoma spp, Necator americanus)
309
(167)Fever, cough, conjunctivitis, coryza, diffuse rash
Measles
310
(167) Small, irregular red spots on buccal/lingual mucosa with blue-white centers
Koplik spots (measles [rubeola] virus)
311
(296) Bounding pulses, wide pulse pressure, diastolic heart murmur, head bobbing
Aortic regurgitation
312
(296) Systolic ejection murmur (crescendo-decrescendo), narrow pulse pressure, pulsus parvus et tardus
Aortic stenosis
313
(296) Continuous “machinelike” heart murmur
PDA (close with indomethacin; keep open with PGE analogs)
314
(308 )Chest pain on exertion
Angina (stable: with moderate exertion; unstable: with minimal exertion or at rest)
315
(308) Chest pain with ST depressions on ECG
Angina (⊝ troponins) or NSTEMI (⊕ troponins)
316
(314) Chest pain, pericardial effusion/friction rub, persistent fever following MI
Postcardiac injury syndrome (autoimmune-mediated post-MI fibrinous pericarditis, 2 weeks to several months after acute episode)
317
(317) Distant heart sounds, distended neck veins, hypotension
Beck triad of cardiac tamponade
318
(318) Painful, raised red lesions on pads of fingers/toes
Osler nodes (infective endocarditis, immune complex deposition)
319
(318) Painless erythematous lesions on palms and soles
Janeway lesions (infective endocarditis, septic emboli/ microabscesses)
320
(318) Splinter hemorrhages in fingernails
Infective endocarditis
321
(318) Retinal hemorrhages with pale centers
Roth spots (infective endocarditis)
322
(320) Telangiectasias, recurrent epistaxis, skin discoloration, arteriovenous malformations, GI bleeding, hematuria
Hereditary hemorrhagic telangiectasia (Osler-WeberRendu syndrome
323
(342) Polyuria, polydipsia
Primary polydipsia, diabetes insipidus (central, nephrogenic)
324
(343) No lactation postpartum, absent menstruation, cold intolerance
Sheehan syndrome (severe postpartum hemorrhage leading to pituitary infarction)
325
(343) Heat intolerance, weight loss, palpitations
Hyperthyroidism
326
(343) Cold intolerance, weight gain, brittle hair
Hypothyroidism
327
(343) Cutaneous/dermal edema due to deposition of mucopolysaccharides in connective tissue
Myxedema (caused by hypothyroidism or hyperthyroidism [Graves disease])
328
(348) Facial muscle spasm upon tapping
Chvostek sign (hypocalcemia)
329
(348) Carpal spasm upon inflation of BP cuff
Trousseau sign (hypocalcemia)
330
(351) Rapid, deep, labored breathing/hyperventilation
Diabetic ketoacidosis (Kussmaul respirations)
331
(353) Skin hyperpigmentation, orthostatic hypotension, fatigue, weakness, muscle aches, weight loss, GI disturbances
Chronic 1° adrenal insufficiency (Addison disease) leading to increase ACTH, increase MSH
332
(353) Shock, altered mental status, vomiting, abdominal pain, weakness, fatigue in patient under glucocorticoid therapy
Acute adrenal insufficiency (adrenal crisis)
333
(356) Pancreatic, pituitary, parathyroid tumors
MEN1 (autosomal dominant MEN1 mutation)
334
(356) Medullary thyroid carcinoma, parathyroid hyperplasia, pheochromocytoma
MEN2A (autosomal dominant RET mutation)
335
(356) Medullary thyroid carcinoma, pheochromocytoma, mucosal neuromas, marfanoid habitus
MEN2B (autosomal dominant RET mutation)
336
(357) Cutaneous flushing, diarrhea, bronchospasm, heart murmur
Carcinoid syndrome (increase urinary 5-HIAA); indicates systemic dissemination (eg, post liver metastases)
337
(357) Jaundice, palpable distended non-tender gallbladder
Courvoisier sign (distal malignant obstruction of biliary tree)
338
(384) Vomiting blood following gastroesophageal lacerations
Mallory-Weiss syndrome (alcohol use disorder, bulimia nervosa)
339
(384) Dysphagia (esophageal webs), glossitis, iron deficiency anemia
Plummer-Vinson syndrome (may progress to esophageal squamous cell carcinoma
340
(386) Enlarged, hard left supraclavicular node
Virchow node (metastasis from abdominal malignancy)
341
(387) Hematemesis, melena
Upper GI bleeding (eg, peptic ulcer disease)
342
(387) Hematochezia
Lower GI bleeding (eg, colonic diverticulosis
343
(388) Arthralgias, cardiac and neurological symptoms, diarrhea
Whipple disease (Tropheryma whipplei)
344
(390) Severe RLQ pain with palpation of LLQ
Rovsing sign (acute appendicitis)
345
(390) Severe RLQ pain with deep tenderness
McBurney sign (acute appendicitis)
346
(394) Hamartomatous GI polyps, hyperpigmented macules on mouth, feet, hands, genitalia
Peutz-Jeghers syndrome (inherited, benign polyposis can cause bowel obstruction; increase breast/GI cancer risk)
347
(394) Multiple colon polyps, osteomas/soft tissue tumors, impacted/supernumerary teeth
Gardner syndrome (subtype of FAP)
348
(401) Severe jaundice in neonate
Crigler-Najjar syndrome (congenital unconjugated hyperbilirubinemia)
349
(402) Golden brown rings around peripheral cornea
Wilson disease (Kayser-Fleischer rings due to copper accumulation)
350
(403) Female, fat (obese), fertile (multiparity), forty, fair
Cholelithiasis (gallstones)
351
(405) Painless jaundice with enlarged gallbladder
Cancer of pancreatic head obstructing the bile duct
352
(425) Bluish line on gingiva
Burton line (lead poisoning)
353
(427) Short stature, café-au-lait spots, thumb/radial defects, increase incidence of tumors/leukemia, aplastic anemia
Fanconi anemia (genetic loss of DNA crosslink repair; often progresses to AML)
354
(428) Red/pink urine, fragile RBCs
Paroxysmal nocturnal hemoglobinuria
355
(429) Painful blue fingers/toes, hemolytic anemia
Cold agglutinin disease (autoimmune hemolytic anemia caused by Mycoplasma pneumoniae, infectious mononucleosis, CLL
356
(432) Petechiae, mucosal bleeding, prolonged bleeding time
Platelet disorders (eg, Glanzmann thrombasthenia, Bernard Soulier, HUS, TTP, ITP, uremic platelet dysfunction)
357
(434) Fever, night sweats, weight loss
B symptoms of malignancy
358
(435) Skin patches/plaques, Pautrier microabscesses, atypical T cell
Mycosis fungoides (cutaneous T-cell lymphoma) or Sézary syndrome (mycosis fungoides + malignant T cells in blood)
359
(352) Neonate with arm paralysis following difficult birth, arm in “waiter’s tip” position
Erb-Duchenne palsy (superior trunk [C5–C6] brachial plexus injury)
360
(455) Anterior drawer sign ⊕
Anterior cruciate ligament injury
361
(468) Bone pain, bone enlargement, long bone chalk-stick fractures
Osteitis deformans (Paget disease of bone, increase osteoblastic and osteoclastic activity)
362
(472) Swollen, hard, painful finger joints in an elderly individual, pain worse with activity
Osteoarthritis (osteophytes on PIP [Bouchard nodes], DIP [Heberden nodes])
363
(473) Sudden swollen/painful big toe joint, tophi
Gout/podagra (hyperuricemia)
364
(474) Dry eyes, dry mouth, arthritis
Sjögren syndrome (autoimmune destruction of exocrine glands)
365
(475) Urethritis, conjunctivitis, arthritis in a male
Reactive arthritis associated with HLA-B27
366
(476) “Butterfly” facial rash, arthritis, cytopenia, and fever in a young female
Systemic lupus erythematosus
367
(478) Cervical lymphadenopathy, desquamating rash, coronary aneurysms, red conjunctivae and tongue, hand-foot changes
Kawasaki disease (mucocutaneous lymph node syndrome, treat with IVIG and aspirin)
368
(479) Palpable purpura on buttocks/legs, joint pain, abdominal pain (child), hematuria
Immunoglobulin A vasculitis (Henoch-Schönlein purpura, affects skin and kidneys)
369
(480) Painful fingers/toes changing color from white to blue to red with cold or stress
Raynaud phenomenon (vasospasm in extremities)
370
(486) Dark purple skin/mouth nodules in a patient with AIDS
Kaposi sarcoma, associated with HHV-8
371
(491) Pruritic, purple, polygonal planar papules and plaques (6 P’s)
Lichen planus
372
(525) Dorsiflexion of large toe with fanning of other toes upon plantar scrape
Babinski sign (UMN lesion)
373
(526) Truncal ataxia, nystagmus, head tilting, fall towards injured side
Cerebellar lesion (lateral affects voluntary movement of extremities; medial affects axial and proximal movement
374
(526) Hyperphagia, hypersexuality, hyperorality
Klüver-Bucy syndrome (bilateral amygdala lesion)
375
(526) Resting tremor, athetosis, chorea
Basal ganglia lesion
376
(529) Dysphagia, hoarseness, decrease gag reflex, nystagmus, ipsilateral Horner syndrom
Lateral medullary (Wallenberg) syndrome (posterior inferior cerebellar artery lesion)
377
(530) Lucid interval after traumatic brain injury
Epidural hematoma (middle meningeal artery rupture; branch of maxillary artery
378
(530) “Worst headache of my life”
Subarachnoid hemorrhage
379
(536) Resting tremor, rigidity, akinesia, postural instability, shuffling gait, micrographia
Parkinson disease (loss of dopaminergic neurons in substantia nigra pars compacta)
380
(536) Chorea, dementia, caudate degeneration
Huntington disease (autosomal dominant CAG repeat expansion)
381
(538) Urinary incontinence, gait apraxia, cognitive dysfunction
Normal pressure hydrocephalus
382
(539) Relapsing and remitting nystagmus, intention tremor, scanning speech, bilateral internuclear ophthalmoplegia
Multiple sclerosis
383
(540) Rapidly progressive limb weakness that ascends following GI/upper respiratory infection
Guillain-Barré syndrome (acute inflammatory demyelinating polyneuropathy)
384
(541) Café-au-lait spots, Lisch nodules (iris hamartoma), cutaneous neurofibromas, pheochromocytomas, optic gliomas
Neurofibromatosis type I
385
(541) Vascular birthmark (port-wine stain) of the face
Nevus flammeus (benign, but associated with SturgeWeber syndrome)
386
(541) Renal cell carcinoma (bilateral), hemangioblastomas, angiomatosis, pheochromocytoma
von Hippel-Lindau disease (deletion of VHL on chromosome 3p)
387
(541) Bilateral vestibular schwannomas
Neurofibromatosis type II
388
(545) Hyperreflexia, hypertonia, Babinski sign present
UMN damage
389
(545) Hyporeflexia, hypotonia, atrophy, fasciculations
LMN damage
390
(547) Staggering gait, frequent falls, nystagmus, hammer toes, diabetes mellitus, hypertrophic cardiomyopathy
Friedreich ataxia
391
(548) Unilateral facial drooping involving forehead
LMN facial nerve (CN VII) palsy; UMN lesions spare the forehead
392
(550) Episodic vertigo, tinnitus, sensorineural hearing loss
Ménière disease
393
(557) Ptosis, miosis, anhidrosis
Horner syndrome (sympathetic chain lesion)
394
(560) Conjugate horizontal gaze palsy, horizontal diplopia
Internuclear ophthalmoplegia (damage to MLF; may be unilateral or bilateral)
395
(577) “Waxing and waning” level of consciousness (acute onset), decrease attention span, decrease level of arousal
Delirium (usually 2° to other cause)
396
(606) Polyuria, renal tubular acidosis type II, growth retardation, electrolyte imbalances, hypophosphatemic rickets
Fanconi syndrome (multiple combined dysfunction of the proximal convoluted tubule)
397
(615) Periorbital and/or peripheral edema, proteinuria (> 3.5 g/ day), hypoalbuminemia, hypercholesterolemia
Nephrotic syndrome
398
(617) Hereditary nephritis, sensorineural hearing loss, retinopathy, anterior lenticonus
Alport syndrome (mutation in type IV collagen)
399
(626) Wilms tumor, macroglossia, organomegaly, hemihyperplasia, omphalocele
Beckwith-Wiedemann syndrome (WT2 mutation)
400
(657) Streak ovaries, congenital heart disease, horseshoe kidney, cystic hygroma, short stature, webbed neck, lymphedema
Turner syndrome (45,XO)
401
(667) Ovarian fibroma, ascites, pleural effusion
Meigs syndrome
402
(670) Red, itchy, swollen rash of nipple/areola
Paget disease of the breast (sign of underlying neoplasm)
403
(671) Fibrous plaques in tunica albuginea of penis with abnormal curvature
Peyronie disease (connective tissue disorder)
404
(694) Pink complexion, dyspnea, hyperventilation
Emphysema (“pink puffer,” centriacinar [tobacco smoking] or panacinar [α1-antitrypsin deficiency])
405
(695) Hypoxemia, polycythemia, hypercapnia
Chronic bronchitis (hypertrophy and hyperplasia of mucus-secreting glands, “blue bloater”
406
(697) Bilateral hilar adenopathy, uveitis
Sarcoidosis (noncaseating granulomas)
407
(58) Colonies of Pseudomonas in lungs
Cystic fibrosis (autosomal recessive mutation in CFTR gene leading to fat-soluble vitamin deficiency and mucous plugs)
408
(61) Decrease AFP on second trimester screening
Down syndrome, Edwards syndrome
409
(61) Decrease β-hCG, decrease PAPP-A on first trimester screening
Down syndrome
410
(67) Increase serum homocysteine, increase methylmalonic acid, decrease folate
Vitamin B12 deficiency
411
(113) Anti-histone antibodies
Drug-induced lupus
412
(114) Decrease T cells, decrease PTH, decrease Ca2+, absent thyme shadow on CXR
Thymic aplasia (DiGeorge syndrome, velocardiofacial syndrome)
413
(115) Recurrent infections, eczema, thrombocytopenia
Wiskott-Aldrich syndrome
414
(115) Large granules in phagocytes, immunodeficiency
Chédiak-Higashi disease (congenital failure of phagolysosome formation)
415
(132) Optochin sensitivity
Sensitive: S pneumoniae; resistant: viridans streptococci (S mutans, S sanguis)
416
(132) Novobiocin response
Sensitive: S epidermidis; resistant: S saprophyticus
417
(132) Bacitracin response
Sensitive: S pyogenes (group A); resistant: S agalactiae (group B)
418
(137) Branching gram ⊕ rods with sulfur granules
Actinomyces israelii
419
(138) Hilar lymphadenopathy, peripheral granulomatous lesion in middle or lower lung lobes (can calcify)
Ghon complex (1° TB: Mycobacterium bacilli
420
(140) “Thumb sign” on lateral neck x-ray
Epiglottitis (Haemophilus influenzae)
421
(147) Bacteria-covered vaginal epithelial cells, ⊕ whiff test
Clue cells” (Gardnerella vaginalis)
422
(153) Ring-enhancing brain lesion on CT/MRI in AIDS
Toxoplasma gondii (multiple), CNS lymphoma (may be solitary
423
(155) Dilated cardiomyopathy with apical atrophy, megacolon, megaesophagus
Chagas disease (Trypanosoma cruzi)
424
(162) Atypical lymphocytes, heterophile antibodies
Infectious mononucleosis (EBV infection)
425
(167) Narrowing of upper trachea and subglottis (Steeple sign) on x-ray
Croup (parainfluenza virus)
426
(169) Eosinophilic inclusion bodies in cytoplasm of hippocampal and cerebellar neurons
Negri bodies of rabies
427
(207) Psammoma bodies
Meningiomas, papillary thyroid carcinoma, mesothelioma, papillary serous carcinoma of the endometrium and ovary
428
(302) “Boot-shaped” heart on x-ray
Tetralogy of Fallot (due to RVH)
429
(304) Rib notching (inferior surface, on x-ray)
Coarctation of the aorta
430
(311) “Delta wave” on ECG, short PR interval, supraventricular tachycardia
Wolff-Parkinson-White syndrome (bundle of Kent bypasses AV node)
431
(317) Electrical alternans (alternating amplitude on ECG)
Cardiac tamponade
432
(319) Granuloma with giant cells after pharyngeal infection
Aschoff bodies (rheumatic fever)
433
(347) Empty-appearing nuclei with central clearing of thyroid cells
“Orphan Annie” eyes nuclei (papillary carcinoma of the thyroid)
434
(349) “Brown” tumor of bone
Hyperparathyroidism or osteitis fibrosa cystica (deposited hemosiderin from hemorrhage gives brown color)
435
(354) Hypertension , hypokalemia, metabolic alkalosis
1° hyperaldosteronism (eg, Conn syndrome)
436
(386) Mucin-filled cell with peripheral nucleus
“Signet ring” cells (diffuse gastric carcinoma)
437
(388) Anti-transglutaminase/anti-gliadin/anti-endomysial antibodies
Celiac disease (diarrhea, weight loss)
438
(389) Narrowing of bowel lumen on barium x-ray
String sign” (Crohn disease)
439
(389) Lead pipe” appearance of colon on abdominal imaging
Ulcerative colitis (loss of haustra)
440
(394) Thousands of polyps on colonoscopy
Familial adenomatous polyposis (autosomal dominant, mutation of APC gene)
441
(395) Apple core” lesion on barium enema x-ray
Colorectal cancer (usually left-sided)
442
(398) Eosinophilic cytoplasmic inclusion in liver cell
Mallory body (alcoholic liver disease)
443
(398) Triglyceride accumulation in liver cell vacuoles
Fatty liver disease (alcoholic or metabolic syndrome)
444
(398) Anti-smooth muscle antibodies (ASMAs), anti-liver/ kidney microsomal-1 (anti-LKM1) antibodies
Autoimmune hepatitis
445
(399) “Nutmeg” appearance of liver
Chronic passive congestion of liver due to right heart failure or Budd-Chiari syndrome
446
(402) Antimitochondrial antibodies (AMAs)
1° biliary cholangitis (female, cholestasis, portal hypertension)
447
(402) Low serum ceruloplasmin
Wilson disease (hepatolenticular degeneration; KayserFleischer rings due to copper accumulation)
448
(405) Migratory thrombophlebitis (leading to migrating DVTs and vasculitis)
Trousseau syndrome (adenocarcinoma of pancreas)
449
(421) Hypersegmented neutrophils
Megaloblastic anemia (vitamin B12 deficiency: neurologic symptoms; folate deficiency: no neurologic symptoms)
450
(422) Basophilic nuclear remnants in RBCs
Howell-Jolly bodies (due to splenectomy or nonfunctional spleen)
451
(422) Basophilic stippling of RBCs
Sideroblastic anemias, thalassemias
452
(424) Hypochromic, microcytic anemia
Iron deficiency anemia, lead poisoning, thalassemia (fetal hemoglobin sometimes presen
453
(425) Hair on end” (“crew cut”) appearance on x-ray
β-thalassemia, sickle cell anemia (marrow expansion)
454
(432) Anti-GpIIb/IIIa antibodies
Immune thrombocytopenia
455
(433) High level of d-dimers
High level of d-dimers
456
(434) Giant B cells with bilobed nucleus with prominent inclusions (“owl’s eye”)
Reed-Sternberg cells (Hodgkin lymphoma)
457
(435) Sheets of medium-sized lymphoid cells with scattered pale, tingible body–laden macrophages (“starry sky” histology)
Burkitt lymphoma (t[8:14] c-myc activation, associated with EBV; “starry sky” made up of malignant cells
458
(436) Lytic (“punched-out”) bone lesions on x-ray
Multiple myeloma
459
(436) Monoclonal spike on serum protein electrophoresis
Multiple myeloma (usually IgG or IgA) Waldenström macroglobulinemia (IgM) Monoclonal gammopathy of undetermined significance
460
(436) Stacks of RBCs
Rouleaux formation (high ESR, multiple myeloma)
461
(437) Myeloperoxidase ⊕ cytoplasmic inclusions in myeloblasts, with increase circulating myeloblasts
Auer rods (APL)
462
(437) WBCs that look “smudged”
CLL
463
(439) “Tennis racket”-shaped cytoplasmic organelles (EM) in Langerhans cells
Birbeck granules (Langerhans cell histiocytosis)
464
(470) “Soap bubble” in femur or tibia on x-ray
Giant cell tumor of bone (generally benign)
465
(471) Raised periosteum (creating a “Codman triangle”)
Aggressive bone lesion (eg, osteosarcoma, Ewing sarcoma
466
(471) Onion skin” periosteal reaction
Ewing sarcoma (malignant small blue cell tumor)
467
(472) IgM antibody that targets IgG Fc region
Rheumatoid arthritis (systemic inflammation, joint pannus, boutonniere and swan neck deformities)
468
(473) Rhomboid crystals, ⊕ birefringent
Pseudogout (calcium pyrophosphate dihydrate crystals)
469
(473) Needle-shaped, ⊝ birefringent crystals
Gout (monosodium urate crystals
470
(473) Increase uric acid levels
Gout, Lesch-Nyhan syndrome, tumor lysis syndrome, loop and thiazide diuretics
471
(475) “Bamboo spine” on x-ray
Ankylosing spondylitis (chronic inflammatory arthritis: HLA-B27)
472
(476) Antinuclear antibodies (ANAs: anti-Smith and antidsDNA)
LE (type III hypersensitivity)
473
(479) Antineutrophil cytoplasmic antibodies (ANCAs)
Microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis, and primary sclerosing cholangitis (MPO-ANCA/p-ANCA); granulomatosis with polyangiitis (PR3-ANCA/c-ANCA)
474
(481) Anticentromere antibodies
Limited scleroderma (CREST syndrome)
475
(481) Anti-Scl-70 (anti-DNA topoisomerase-I) and anti-RNA polymerase III antibodie
Diffuse scleroderma
476
(489) Anti-desmoglein (anti-desmosome) antibodies
Pemphigus vulgaris
477
(489) Antihemidesmosome antibodies
Bullous pemphigoid
478
(493) Keratin pearls on a skin biopsy
Squamous cell carcinoma
479
(501) increase AFP in amniotic fluid/maternal serum
Dating error, anencephaly, spina bifida (open neural tube defects)
480
(530) Bloody or yellow tap on lumbar puncture
Xanthochromia (due to subarachnoid hemorrhage)
481
(536) Eosinophilic cytoplasmic inclusion in neuron
Lewy body (Parkinson disease and Lewy body dementia)
482
(536) Extracellular amyloid deposition in gray matter of brain
Senile plaques (Alzheimer disease)
483
(536)Depigmentation of neurons in substantia nigra
Parkinson disease (basal ganglia disorder: rigidity, resting tremor, bradykinesia)
484
(536) Protein aggregates in neurons from hyperphosphorylation of tau protein
Neurofibrillary tangles (Alzheimer disease) and Pick bodies (Pick disease)
485
(536) Silver-staining spherical aggregation of tau proteins in neurons
Pick bodies (frontotemporal dementia: progressive dementia, changes in personality)
486
(542) Pseudopalisading pleomorphic tumor cells on brain biopsy
Glioblastoma
487
(544) Small blue cells surrounding central area of neuropil
Homer-Wright rosettes (neuroblastoma, medulloblastoma)
488
(614) “Waxy” casts with very low urine flow
Chronic end-stage renal disease
489
(614) WBC casts in urine
Acute pyelonephritis, transplant rejection, tubulointerstitial inflammation
490
(614) RBC casts in urine
Glomerulonephritis
491
(616) Anti–glomerular basement membrane antibodies
Goodpasture syndrome (glomerulonephritis and hemoptysis)
492
(616) Cellular crescents in Bowman capsule
Rapidly progressive (crescentic) glomerulonephritis
493
(617) “Wire loop” glomerular capillary appearance on light microscopy
Diffuse proliferative glomerulonephritis (usually seen with lupus)
494
(616) Linear appearance of IgG deposition on glomerular and alveolar basement membranes
Goodpasture syndrome
495
(616) “Lumpy bumpy” appearance of glomeruli on immunofluorescence
Infection-related glomerulonephritis (due to deposition of IgG, IgM, and C3)
496
(616) Necrotizing vasculitis (lungs) and necrotizing glomerulonephritis
Granulomatosis with polyangiitis (PR3-ANCA/c-ANCA) and Goodpasture syndrome (anti–basement membrane antibodies)
497
(617) “Tram-track” appearance of capillary loops of glomerular basement membranes on light microscopy
Membranoproliferative glomerulonephritis
498
(618) Nodular hyaline deposits in glomeruli
Kimmelstiel-Wilson nodules (diabetic glomerulonephropathy)
499
(618) Nodular hyaline deposits in glomeruli
Kimmelstiel-Wilson nodules (diabetic glomerulonephropathy
500
(618) Podocyte fusion or “effacement” on electron microscopy
Minimal change disease (child with nephrotic syndrome)
501
(618)“Spikes” on basement membrane, “domelike” subepithelial deposits
Membranous nephropathy (nephrotic syndrome)
502
(621) Thyroidlike appearance of kidney
Chronic pyelonephritis (usually due to recurrent infections)
503
(623) Granular casts in urine
Acute tubular necrosis (eg, ischemia or toxic injury)
504
(654) hCG elevated
Multifetal gestation, hydatidiform moles, choriocarcinomas, Down syndrome
505
(664) Dysplastic squamous cervical cells with “raisinoid” nuclei and hyperchromasia
Koilocytes (HPV: predisposes to cervical cancer)
506
(667) Sheets of uniform “fried egg” cells, increase hCG, increase LDH
Dysgerminoma
507
(667) Glomeruluslike structure surrounding vessel in germ cells
Schiller-Duval bodies (yolk sac tumor)
508
(667) Disarrayed granulosa cells arranged around collections of eosinophilic fluid
Call-Exner bodies (granulosa cell tumor of the ovary)
509
(668) “Chocolate cyst” of ovary
Endometriosis (frequently involves both ovaries)
510
(669) Mammary gland (“blue domed”) cyst
Fibrocystic change of the breast
511
(673) Rectangular, crystal-like, cytoplasmic inclusions in Leydig cells
Reinke crystals (Leydig cell tumor)
512
(693) Thrombi made of white/red layers
Lines of Zahn (arterial thrombus, layers of platelets/ RBCs)
513
(695) Hexagonal, double-pointed, needlelike crystals in bronchial secretions
Bronchial asthma (Charcot-Leyden crystals: eosinophilic granules)
514
(695) Desquamated epithelium casts in sputum
Curschmann spirals (bronchial asthma; can result in whorled mucous plugs
515
(696) “Honeycomb lung” on x-ray or CT
Idiopathic pulmonary fibrosis
516
(698) Iron-containing nodules in alveolar septum
Ferruginous bodies (asbestosis: increase chance of lung cancer)
517
(706) Bronchogenic apical lung tumor on imaging
Pancoast tumor (can compress cervical sympathetic chain and cause Horner syndrome)
518
(55) 57 Mitochondrial inheritance
Disease occurs in all offspring of affected females (maternal inheritance pattern), heteroplasmy
519
(60) 61 Intellectual disability
Down syndrome, fragile X syndrome
520
(66) Vitamin deficiency (USA)
Folate (pregnant women are at high risk; body stores only 3- to 4-month supply)
521
(98) HLA-DR3
DM type 1, SLE, Graves disease, Hashimoto thyroiditis, Addison disease
522
(86) Lysosomal storage disease
Gaucher disease
523
(98) HLA-DR4
Rheumatoid arthritis, type 1 DM, Addison disease
524
(144) H pylori
Bacteria associated with gastritis, peptic ulcer disease, and gastric malignancies (eg, adenocarcinoma, MALToma)
525
(151) Opportunistic respiratory infection in AIDS
Pneumocystis jirovecii
526
(162) HSV-1
Viral encephalitis affecting temporal lobe
527
(171) Hepatitis C
Viral infection 2° to blood transfusion
528
(175) S aureus, B cereus
Food poisoning (exotoxin mediated)
529
(176) S aureus, Pseudomonas, other gram ⊝ rods
Healthcare-associated pneumonia
530
(177) S pneumoniae
Bacterial meningitis (> 6 months old
531
(177) Group B streptococcus/E coli/Listeria (newborns) Group B streptococcus/E coli/Listeria (newborns)
Bacterial meningitis (newborns 0–6 months old)
532
(177) Salmonella and S aureus
Osteomyelitis in sickle cell disease
533
(177) S aureus (most common overall)
Osteomyelitis
534
(177) S aureus, Pseudomonas, Candida
Osteomyelitis with injection drug use
535
(179) E coli, Staphylococcus saprophyticus
UTI
536
(180) C trachomatis
Bacterial STI
537
(182) C trachomatis (subacute), N gonorrhoeae (acute
Pelvic inflammatory disease
538
(219) Prostate, breast >> lung > kidney, colon
Metastases to bone
539
(219) Lung > breast >> melanoma > colon, prostate
Metastases to brain
540
(219) Lung > breast >> melanoma > colon, prostate
Metastases to brain
541
(219) Colon > breast >> pancreas, lung, prostate
Metastases to liver
542
(292) Increase ventricular filling pressure (eg, MR, AR, HF, thyrotoxicosis), common in dilated ventricles
S3 heart sound
543
(292) Stiff/hypertrophic ventricle (aortic stenosis, restrictive cardiomyopathy)
S4 heart sound
544
(296) VSD, tricuspid regurgitation, mitral regurgitation
Holosystolic murmur
545
(296) Aortic stenosis
Ejection click
546
(296) Rheumatic heart disease (late and highly specific sequelae of rheumatic fever)
Mitral stenosis
547
(296) Mitral stenosis
Opening snap
548
(296) Mitral valve prolapse
Heart murmur, congenital
549
(302) Tetralogy of Fallot (most common), D-transposition of great arteries, persistent truncus arteriosus, total anomalous pulmonary venous return, tricuspid atresia
Cyanotic heart disease (early)
550
(303) Eisenmenger syndrome (caused by VSD, ASD, PDA)
Late cyanotic shunt (uncorrected left to right becomes right to left)
551
(303) VSD > ASD > PDA
Congenital heart disease (left-to-right shunts)
552
(304) Renal/renovascular diseases (eg, fibromuscular dysplasia), atherosclerotic renal artery stenosis, 1° hyperaldosteronism, or obstructive sleep apnea
Hypertension, 2°
553
(306) Marfan syndrome (cystic medial degeneration), 3° syphilis (obliterative endarteritis of vasa vasorum)
Aortic aneurysm, thoracic
554
(306) Atherosclerosis, tobacco use
Aortic aneurysm, abdominal
555
(305) Abdominal aorta > coronary artery > popliteal artery > carotid artery
Sites of atherosclerosis
556
(307) Hypertension (most important risk factor)
Aortic dissection
557
(311)Atrial fibrillation (associated with high risk of emboli)
Irregularly irregular rhythm on ECG with no discrete P waves
558
(316) Cor pulmonale
Right heart failure due to a pulmonary cause
559
(318) Mitral > aortic, tricuspid (injection drug use)
Heart valve in infective endocarditis
560
(318) S aureus (acute, injection drug use, tricuspid valve), viridans streptococci (subacute, dental procedure), S gallolyticus (colon cancer), gram ⊝ (HACEK), culture ⊝ (Coxiella, Bartonella)
Infective endocarditis presentation associated with bacterium
561
(320) Metastasis, myxoma (90% in left atrium; “ball valve”)
Cardiac tumor (adults)
562
(343) Pituitary adenoma (usually benign tumor)
Hypopituitarism
563
(320) Rhabdomyoma (associated with tuberous sclerosis)
Cardiac 1° tumor (kids)
564
(339) 21-hydroxylase deficiency
Congenital adrenal hyperplasia, hypotension
565
(354) Thyroid dysgenesis/dyshormonogenesis, iodine deficiency
Congenital hypothyroidism (cretinism)
566
(347) Papillary carcinoma (RET/PTC rearrangements, BRAF mutations)
Thyroid cancer
567
(348) Accidental excision during thyroidectomy
Hypoparathyroidism
568
(349) Adenomas, hyperplasia, carcinoma
1° hyperparathyroidism
569
(349) Hypocalcemia of chronic kidney disease
2° hyperparathyroidism
570
(352)* Exogenous glucocorticoids * Adrenocortical adenoma (secretes excess cortisol) * ACTH-secreting pituitary adenoma (Cushing disease) * Paraneoplastic (due to ACTH secretion by tumors)
Cushing syndrome
571
(354) Bilateral adrenal hyperplasia or adenoma (Conn syndrome)
1° hyperaldosteronism
572
(354) Neuroblastoma (malignant)
Tumor of the adrenal medulla (kids)
573
(355) Pheochromocytoma (usually benign)
Tumor of the adrenal medulla (adults)
574
(357) Zollinger-Ellison syndrome (gastrinoma of duodenum or pancreas), associated with MEN1
Refractory peptic ulcers and high gastrin levels
575
(385) Squamous cell carcinoma (worldwide); adenocarcinoma (US)
Esophageal cancer
576
(386) Cushing ulcer (increase vagal stimulation leading to increase ACh leading to increase H+ production)
Acute gastric ulcer associated with CNS injury
577
(386) Curling ulcer (hypovolemia leading to mucosal ischemia)
Acute gastric ulcer associated with severe burns
578
(386) Krukenberg tumor (mucin-secreting signet ring cells)
Bilateral ovarian metastases from gastric carcinoma
579
(386) Predisposition to gastric carcinoma (can also cause pernicious anemia)
Chronic atrophic gastritis (autoimmune)
580
(389) Skip lesions (Crohn disease)
Alternating areas of transmural inflammation and normal colon
581
(390) Sigmoid colon
Site of diverticulosis
582
(391) Zenker diverticulum
Diverticulum in pharynx
583
(399) HBV (+/– cirrhosis) or other causes of cirrhosis (eg, alcoholic liver disease, hemochromatosis), aflatoxins
Hepatocellular carcinoma
584
(401) Dubin-Johnson syndrome (inability of hepatocytes to secrete conjugated bilirubin into bile)
Congenital conjugated hyperbilirubinemia (black liver)
585
(401) Gilbert syndrome (benign congenital unconjugated hyperbilirubinemia)
Hereditary harmless jaundice
586
(402) Hereditary ATP7B mutation (copper buildup in liver, brain, cornea [Kayser-Fleischer rings], kidneys)
Wilson disease
587
(402) Multiple blood transfusions or hereditary HFE mutation (can result in heart failure, “bronze diabetes,” and increase risk of hepatocellular carcinoma)
Hemochromatosis
588
(404) Gallstones, alcohol
Pancreatitis (acute)
589
(404) Alcohol (adults), cystic fibrosis (children)
Pancreatitis (chronic)
590
(424) Iron deficiency, thalassemias, lead poisoning, sideroblastic anemia
Microcytic anemia
591
(428) Sickle cell anemia (hemoglobin S)
Autosplenectomy (fibrosis and shrinkage), Howell-Jolly bodies
592
(432) Bernard-Soulier syndrome (defect in platelet adhesion to von Willebrand factor)
Platelet disorder with GpIb deficiency
593
(432) Glanzmann thrombasthenia (defect in platelet-to-platelet aggregation and platelet plug formation)
Platelet disorder with GpIIb/IIIa deficiency
594
(433) von Willebrand disease
Inherited bleeding disorder
595
(433) Leiden (also associated with recurrent pregnancy loss)
Hereditary thrombophilia
596
(433) Stroke, snake bite, sepsis, trauma, obstetric complications, acute pancreatitis, malignancy, nephrotic syndrome, transfusion
DIC
597
(434) Hodgkin lymphoma
Malignancy associated with noninfectious fever
598
(434) Nodular sclerosis
Type of Hodgkin lymphoma (most common)
599
(435) Follicular lymphoma (BCL-2 activation, anti-apoptotic oncogene)
t(14;18)
600
(435) Burkitt lymphoma (c-myc fusion, transcription factor oncogene)
t(8;14)
601
(435) Diffuse large B-cell lymphoma
Type of non-Hodgkin lymphoma (most common in adults)
602
(436) Multiple myeloma
1° bone tumor (older adults)
603
(437) ALL: child, CLL: adult > 60, AML: adult ∼ 65, CML: adult 45–85
Age ranges for patient with ALL/CLL/AML/CML
604
(437) Leukemia, brain tumors
Malignancy (kids)
605
(437) Philadelphia chromosome, CML (BCR-ABL oncogene, tyrosine kinase activation), more rarely associated with ALL
t(9;22)
606
(467) Osteoporosis
Vertebral compression fracture
607
(475) Psoriatic arthritis, ankylosing spondylitis, IBD-associated arthritis, reactive arthritis
HLA-B27
608
(476) Renal disease (most common), infections, cardiovascular disease (accelerated CAD)
Death in SLE
609
(478) Risk of ipsilateral blindness due to occlusion of ophthalmic artery; polymyalgia rheumatica
Giant cell arteritis
610
(478) Buerger disease (strongly associated with tobacco smoking, Raynaud phenomenon)
Recurrent inflammation/thrombosis of medium-vessels in extremities
611
(486) Strawberry hemangioma (grows rapidly and regresses spontaneously by 5–8 years of age)
Benign vascular tumor of infancy
612
(491) Pityriasis rosea
Herald patch (Christmas tree distribution)
613
(493) Precursor to squamous cell carcinoma
Actinic keratosis
614
(502) Chiari I malformation (associated with spinal cord cavitations [eg, syringomyelia]
Cerebellar tonsillar herniation
615
(526) Wernicke-Korsakoff syndrome (with bilateral lesions)
Bilateral mamillary body lesions with thiamine deficiency
616
(530) Rupture of middle meningeal artery (trauma; lentiform shaped)
Epidural hematoma
617
(530) Rupture of middle meningeal artery (trauma; lentiform shaped)
Epidural hematoma
618
(530) Rupture of bridging veins (crescent shaped)
Subdural hematoma
619
(536) Alzheimer disease, vascular dementia (multiple infarcts)
Dementia
620
(539) Multiple sclerosis
Demyelinating disease in young women
621
(542) Metastasis, glioblastoma (malignant), meningioma, hemangioblastoma
Brain tumor (adults)
622
(542) Prolactinoma
Galactorrhea, amenorrhea
623
(544) Infratentorial: medulloblastoma (cerebellum) or supratentorial: craniopharyngioma
Brain tumor (children)
624
(546) Amyotrophic lateral sclerosis
Combined (UMN and LMN) motor neuron degeneration
625
(546) Tabes dorsalis (3° syphilis), subacute combined degeneration (dorsal columns, lateral corticospinal, spinocerebellar tracts affected)
Degeneration of dorsal column fibers
626
(618) Minimal change disease
Nephrotic syndrome (children)
627
(619) Uric acid
Kidney stones (radiolucent)
628
(619) Calcium (most common), struvite (ammonium), cystine (faintly radiopaque)
Kidney stones (radiopaque)
629
(625) Renal cell carcinoma: associated with tobacco smoking and VHL (clear cell subtype); paraneoplastic syndromes (EPO, renin, PTHrP, ACTH)
Renal malignancy (in males)
630
(567) Turner syndrome (45,XO or 45,XO/46,XX mosaic)
1° amenorrhea
631
(658) Kallmann syndrome (neuron migration failure)
Hypogonadotropic hypogonadism with anosmia
632
(664) DES exposure in utero
Clear cell adenocarcinoma of the vagina
633
(666) Serous cystadenoma
Ovarian tumor (benign, bilateral)
634
(66) Serous carcinoma
Ovarian tumor (malignant)
635
(668) Leiomyoma (estrogen dependent, not precancerous)
Benign tumor of myometrium
636
(663-668) Endometrial carcinoma (most common in resource-rich countries); cervical cancer (most common worldwide)
Gynecologic malignancy (most common)
637
(669) Fibrocystic change (in premenopausal females); carcinoma (in postmenopausal females)
Breast mass
638
(669) Fibroadenoma
Breast tumor (benign, young woman)
639
(670) Invasive ductal carcinoma
Breast cancer
640
(672) Seminoma (malignant, radiosensitive), increase PLAP
Testicular tumor
641
(674) BPH
Bladder outlet obstruction in men
642
(692) Virchow triad (increase risk of thrombosis)
Hypercoagulability, endothelial damage, blood stasis
643
(700) Idiopathic, left heart disease, lung diseases/hypoxia, chronic thromboembolism, multifactorial
Pulmonary hypertension
644
(705) Small cell carcinoma of the lung
SIADH
645
(229) Volume of distribution
Vd= amount of drug in the body/plasma drug concentration
646
(229) Half-life
t = 0.7 x Vd/CL ½
647
(229) Loading dose
LD= Cp x Vd / F
648
(229) Drug clearance
CL= rate of elimination of drug/plasma drug concentration=Vd x Ke (elimination)
649
(233) Therapeutic index
TI = median toxic dose/median effective dose = TD50/ED50
650
(229) Maintenance dose
Maintenance dose = Cp x CL x τ/F
651
(258) Odds ratio (for case-control studies)
OR=_a/c =_ad b/d bc
652
(258) Relative risk
RR= __a/(a + b) c/(c + d)
653
(258) Attributable risk
AR = __a - __c a +b c+ d
654
(258) Relative risk reduction
RRR = (ARC – ART)/ARC
655
(258) Absolute risk reduction
ARR = __a - __c a +b c+ d
656
(258) Number needed to treat
NNT = 1/ARR
657
(258) Number needed to harm
NNH = 1/AR
658
(259) Likelihood ratio +
LR+ = sensitivity/(1 – specificity) = TP rate/FP rate
659
(259) Likelihood ratio –
LR– = (1 – sensitivity)/specificity = FN rate/TN rate
660
(260) Sensitivity
Sensitivity = TP / (TP + FN)
661
(260) Specificity
Specificity = TN / (TN + FP)
662
(260) Positive predictive value
PPV = TP / (TP + FP)
663
(260) Negative predictive value
NPV = TN / (TN + FN)
664
(290) Cardiac output
*CO= rate of O2 consumption/(arterial O2 content − venous O2 content) *CO = stroke volume × heart rate
665
(290) Mean arterial pressure
MAP = CO × total peripheral resistance (TPR) MAP (at resting HR) = 2⁄3 DBP + 1⁄3 SBP = DBP + 1⁄3 PP
666
(290) Stroke volume
SV = EDV – ESV
667
(290) Ejection fraction
EF= __SV = __EDV - ESV EDV EDV
668
(291) Resistance
Resistance = driving pressure (ΔP)/ flow (Q) = 8η (viscosity) × length/ πr4
669
(301) Capillary fluid exchange
Jv = net fluid flow = Kf[(Pc − Pi) − σ(πc − πi)]
670
(423) Reticulocyte production index
RPI = % reticulocytes × (actual Hct/normal Hct) / maturation time
671
(602) Renal clearance
Cx= (UxV)/Px
672
(602) Glomerular filtration rate
Cinulin = GFR = Uinulin × V/Pinulin = Kf [(PGC – PBS) – (πGC – πBS)
673
(602) Effective renal plasma flow
eRPF = (U)PAH × V/(P)PAH = (C)PAH
674
(603) Filtration fraction
FF = GFR/RPF
675
(604) Fractional excretion of sodium
FeNa+ = V × UNa / GFR × PNa = PCr × UNa / UCr × PNa
676
(612) Henderson-Hasselbalch equation (for extracellular pH)
pH = 6.1 + log[HCO3−]/0.03 Pco 2
677
(612) Winters formula
Pco2 = 1.5 [HCO3–] + 8 ± 2
678
(612) Anion gap
Na+ − (Cl– + HCO3–)
679
(684) Physiologic dead space
VD = VT × PaCO2 − PECO2/PaCO2
680
(686) Pulmonary vascular resistance
PVR = (P)pulm artery – (P)L atrium/ Cardiac output
681
(687) Alveolar gas equation
Pao2 = Pio2 – Paco2/RQ = 150 mm Hga – Paco2 / 0.8
682
K+-sparing diuretic
Amiloride
683
K+ channel blocker (class III antiarrhythmic)
Amiodarone
684
Dihydropyridine Ca2+ channel blocker
Amlodipine
685
Parkinson disease (cholinergic antagonist)
Benztropine
686
Parkinson disease (dopamine agonist; rarely used)
Bromocriptine
687
Generalized anxiety disorder (partial 5-HT1A-receptor agonist)
Buspirone
688
Depression, smoking cessation (NE-DA reuptake inhibitor)
Bupropion
689
Gastritis, peptic ulcer (H2-receptor antagonist)
Cimetidine
690
Gastritis, peptic ulcer (H2-receptor antagonist)
Cimetidine
691
Allergy (2nd-generation antihistamine)
Cetirizine
692
Antibiotic (blocks 50S subunit)
Chloramphenicol
693
Long-acting benzodiazepine
Chlordiazepoxide
694
Typical antipsychotic
Chlorpromazine
695
1st-generation sulfonylurea
Chlorpropamide
696
1st-generation antihistamine
Chlorpheniramine
697
Thiazide diuretic
Chlorthalidone
698
Atypical antipsychotic
Clozapine
699
Tricyclic antidepressant
Clomipramine
700
Infertility due to anovulation (selective estrogen receptor modulator in hypothalamus)
Clomiphene
701
Hypertensive urgency, ADHD (α2-agonist)
Clonidine
702
Tricyclic antidepressant
Doxepin
703
BPH, HTN (α1-antagonist)
Doxazosin
704
K+-sparing diuretic
Eplerenone
705
Depression (selective serotonin reuptake inhibitor)
Fluoxetine
705
Na+ channel blocker (class Ic antiarrhythmic)
Propafenone
705
Typical antipsychotic
Fluphenazine
706
Pregnancy termination (progesterone receptor antagonist)
Mifepristone
707
Used with mifepristone for pregnancy termination (PGE1-synthetic analog)
Misoprostol
708
Opioid receptor antagonist (treats toxicity)
Naloxone
709
Opioid receptor antagonist (prevents relapse)
Naltrexone
710
Hypertensive emergency (increase cGMP/NO)
Nitroprusside
711
Antianginal (increase cGMP/NO)
Nitroglycerin
712
Proton pump inhibitor (inhibits H+/K+-ATPase in parietal cells)
Omeprazole
713
Antifungal (inhibits fungal sterol synthesis)
Ketoconazole
714
Atypical antipsychotic (D2 partial agonist)
Aripiprazole
715
ER ⊕ breast cancer in postmenopausal women (aromatase inhibitor)
Anastrozole
716
Hepatic encephalopathy (decrease ammoniagenic bacteria)
Rifaximin
717
Antituberculous drug/antimicrobial (inhibits DNA-dependent RNA polymerase)
Rifampin
718
Depression, PTSD (selective serotonin reuptake inhibitor)
Sertraline
719
Parkinson disease (MAO-B inhibitor)
Selegiline
720
Insomnia (blocks 5-HT2, α1-adrenergic, and H1 receptors); also weakly inhibits 5-HT reuptake
Trazodone
721
Chronic pain (weak opioid agonist)
Tramadol
722
Smoking cessation (nicotinic ACh receptor partial agonist)
Varenicline
723
Serotonin-norepinephrine reuptake inhibitor
Venlafaxine
724
725
725
726
727